The Complete Guide to Best Free Stock Screener: Everything Value Investors Need to Know
Paying $24,000 per year for a Bloomberg Terminal makes sense if you manage a $500 million fund. It makes no sense for a retail investor managing $50,000. The best free stock screener gives individual value investors access to the same fundamental data that drives institutional decisions, without the institutional price tag.
But "free" comes with trade-offs. Some platforms limit indicator counts. Others restrict geographic coverage. A few gate their most useful features behind upsell walls that make the free tier almost unusable.
This guide maps the entire landscape of free stock screeners, tests each one against real value investing workflows, and identifies which platforms deliver genuine depth at zero cost.
Key Takeaways
- The best free stock screener offers 50+ fundamental indicators at minimum for serious value analysis
- Geographic coverage is the sharpest differentiator: US-only tools miss approximately 70% of global equities
- Composite quality scores (Piotroski F-Score, Altman Z-Score) exist in fewer than a third of free screeners
- Export functionality and saved screens determine whether a tool supports systematic investing or one-off research
- Free does not mean shallow: several platforms now offer 100+ indicators without requiring payment
The Free Screener Landscape in 2026
The market for free stock screeners has shifted over the past three years. Platforms that once charged for basic fundamental screening now offer it for free as a user acquisition strategy. The paid tiers have moved upstream to backtesting, real-time alerts, and API access.
This shift benefits value investors. Five years ago, filtering by EV/EBITDA required a paid subscription on most platforms. Today, it is a standard free feature. The question is no longer "can I screen for free?" but "which free screener gives me the deepest analysis?"
How We Evaluated Each Platform
I tested each screener by running three standardized screens:
Screen 1 (Graham Value): P/E < 15, P/B < 1.5, debt-to-equity < 0.5, market cap > $500M
Screen 2 (Quality Compounder): ROIC > 20%, Piotroski F-Score >= 7, revenue growth > 5%
Screen 3 (Dividend Safety): Dividend yield > 2.5%, payout ratio < 60%, free cash flow positive
Platforms that could run all three screens without a paywall or missing data earned higher marks. Here are the results.
Platform-by-Platform Analysis
ValueMarkers Free Tier
ValueMarkers provides 120+ indicators across 73 global exchanges in its free tier. All three test screens ran without issues. The Piotroski F-Score filter returned companies like Apple (score: 7), Microsoft (score: 8), and Visa (score: 8).
The VMCI composite score is available at no cost, combining Value (35%), Quality (30%), Integrity (15%), Growth (12%), and Risk (8%). The DCF calculator, guru tracker, and glossary are all free. Saved screens are unlimited.
The free tier does have limitations: data refreshes daily rather than in real-time, and advanced backtesting is reserved for paid plans. For screening and research, though, the free tier covers the full workflow.
Finviz Free Tier
Finviz delivers about 70 filters for US equities. Screen 1 (Graham Value) ran smoothly. Screen 2 failed because Finviz does not offer Piotroski F-Score as a filter. Screen 3 ran partially: dividend yield and payout ratio work, but free cash flow requires the Elite plan.
The map visualization is the standout feature. No other free tool matches Finviz's sector heat map for quick market overviews.
Limitations: no international stocks, one saved screen, no CSV export, 15-minute delayed data.
Yahoo Finance Screener
Yahoo Finance offers approximately 30 filters. Screen 1 ran with most fields. Screen 2 could not run because ROIC and Piotroski are unavailable. Screen 3 ran partially.
Yahoo's strength is accessibility. Everyone knows the interface. The weakness is depth. For a quick P/E and market cap filter, it works. For multi-dimensional value analysis, it falls short.
TradingView Free Tier
TradingView provides around 50 fundamental filters across 50+ exchanges. Screen 1 ran on US stocks. Screen 2 failed on Piotroski (unavailable). Screen 3 ran on basic dividend metrics.
TradingView's charting integration is unmatched. If you want to screen fundamentally and then analyze price patterns, this is the best free option for that combined workflow. Pure fundamental screening, however, has gaps.
Stock Analysis Free Tier
Stock Analysis covers about 60 indicators for US equities. All three screens ran successfully. The platform includes Piotroski F-Score, a DCF calculator, and 10-year financial statement access.
The free tier allows 3 saved screens and CSV export. For US-focused value investors who want a complete research workflow at no cost, Stock Analysis is strong.
Geographic limitation is the constraint: US only.
Wisesheets Free Tier
Wisesheets takes a different approach by pulling data directly into Google Sheets or Excel. About 40 data points are available. Screening happens through spreadsheet formulas rather than a visual interface.
This works well for quantitative investors who build custom models. It does not work for visual screening or quick scans.
Test Results: Which Free Screener Ran All Three Screens?
| Platform | Screen 1 (Graham) | Screen 2 (Quality) | Screen 3 (Dividend) | Total Screens Passed |
|---|---|---|---|---|
| ValueMarkers | Pass | Pass | Pass | 3/3 |
| Finviz | Pass | Fail (no Piotroski) | Partial | 1.5/3 |
| Yahoo Finance | Partial | Fail | Partial | 0.5/3 |
| TradingView | Pass | Fail (no Piotroski) | Partial | 1.5/3 |
| Stock Analysis | Pass | Pass | Pass | 3/3 |
| Wisesheets | N/A (spreadsheet) | N/A | N/A | N/A |
Two platforms cleared all three tests: ValueMarkers and Stock Analysis. The differentiator between them is geographic scope. ValueMarkers covers 73 exchanges globally. Stock Analysis covers US equities only.
Building a Complete Research Workflow on a Free Platform
A free screener becomes powerful when you build a repeatable system around it. Here is the workflow I use every week:
Saturday 9:00 AM: Open ValueMarkers. Rerun three saved screens (Graham Value, Quality Compounder, High Dividend). Takes about 2 minutes.
Saturday 9:05 AM: Review new entries, stocks that appeared this week but were not there last week. These are stocks whose fundamentals or prices shifted enough to cross a screening threshold.
Saturday 9:15 AM: For each new entry, check the VMCI Score breakdown. A stock that scores 80+ with strong Quality and Integrity pillars goes on the short list.
Saturday 9:30 AM: For the top 3 new entries, open the DCF calculator. Plug in conservative growth assumptions. Compare the resulting intrinsic value to the current market price.
Saturday 10:00 AM: Read the most recent earnings transcript for any stock where the DCF suggests 20%+ upside. Check the ValueMarkers glossary if any metric needs clarification.
Saturday 10:30 AM: Update the watchlist. Done.
Total weekly time: 90 minutes. Total cost: $0.
Why Most "Best Free Screener" Lists Get It Wrong
Most comparison articles rank screeners by popularity rather than capability. Finviz and Yahoo Finance top every list because they have the largest user bases. But user count does not equal analytical depth.
A screener that 10 million people use for basic P/E filters is not better than a screener that 100,000 people use for Piotroski F-Score, Altman Z-Score, and global coverage. It is more popular, which is a different thing entirely.
This guide ranks by capability for value investing specifically. The metrics that matter are indicator count, quality score availability, exchange coverage, and research tool integration. On those criteria, the rankings look different from what you will find on most "best free screener" roundups.
The Real Cost of "Free"
Every free platform monetizes somehow. Understanding the model helps you evaluate what you are getting.
Ad-supported (Yahoo Finance, Finviz free): You are the product. Ads interrupt your workflow but the data is genuinely free.
Freemium (ValueMarkers, Stock Analysis, TradingView): The free tier is a funnel to paid plans. The data is real and useful. Premium features (backtesting, real-time data, API access) are reserved for paying customers.
Data-selling (some lesser-known platforms): Your screening behavior and watchlists are sold to hedge funds. Read the privacy policy.
The freemium model is the most transparent. You know exactly what you get for free and what costs extra. The screening and research tools are not degraded to push upgrades; they are complete within their scope.
When to Graduate From Free
A free screener handles 90% of individual investor needs. The 10% that requires a paid tier:
- Backtesting: Testing your screen criteria against historical data to see how they would have performed. No free tier offers this.
- Real-time alerts: Getting notified when a stock crosses a screening threshold. Most free platforms update daily.
- API access: Pulling screening data into quantitative models programmatically. This is an institutional-grade feature.
- Priority data refresh: Getting data minutes after market close instead of hours.
If you manage a portfolio over $500,000 or run a systematic quantitative strategy, the paid tier pays for itself. Below that threshold, the free tier is sufficient for manual value investing.
Further reading: SEC Investor.gov · FINRA
Related ValueMarkers Resources
- Enterprise Value to EBITDA (EV/EBITDA) — Enterprise Value to EBITDA is the metric used to how cheaply a stock trades relative to its fundamentals
- Pe Ratio — Glossary entry for Pe Ratio
- Piotroski F-Score — Piotroski F-Score captures the reliability of reported earnings versus underlying cash flow
- Free Stock Screener — related ValueMarkers analysis
- Yahoo Free Stock Screener — related ValueMarkers analysis
- Simply Wall Street — related ValueMarkers analysis
Frequently Asked Questions
what happens if the stock market crashes
Free screeners become your most valuable tool during crashes. In the March 2020 selloff, the number of stocks passing a Graham-style value screen (P/E < 15, P/B < 1.5) increased by roughly 300%. Investors with pre-built screens captured opportunities that disappeared within weeks.
what time does the stock market open
US markets (NYSE, NASDAQ) open at 9:30 AM Eastern Time on weekdays. Pre-market trading starts at 4:00 AM ET. Free screener data updates throughout the trading day, with the most complete snapshot available after the 4:00 PM close.
are stock markets closed today
US stock markets close for 9 federal holidays per year. The NYSE publishes its full holiday calendar each year. Markets also close early at 1:00 PM ET on the day before Independence Day, Thanksgiving, and Christmas.
what time does the stock market close
The NYSE and NASDAQ close regular trading at 4:00 PM Eastern Time. After-hours sessions run until 8:00 PM ET. Free screeners typically process end-of-day data between 5:00 PM and 8:00 PM ET.
when does the stock market open
US markets: 9:30 AM ET. UK: 8:00 AM GMT. Japan: 9:00 AM JST. Screeners with global coverage update data from each exchange as it opens. ValueMarkers tracks 73 exchanges, providing continuous updates throughout the 24-hour global trading cycle.
why is the stock market down today
Market drops can be triggered by economic data misses, central bank decisions, or geopolitical tensions. A free screener's value during down days is filtering out market-wide panic and focusing on individual company fundamentals that have not changed because of a single day's price action.
Written by Javier Sanz, Founder of ValueMarkers | Last updated April 2026
Find the best free stock screener for your investing style. Compare all platforms and start screening on ValueMarkers.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.